Nektar Therapeutics
NASDAQ:NKTR
Nektar Therapeutics
NASDAQ:NKTR
Price:
1.5 USD
-8.54%
Market Closed
Updated:
May 29, 2024
Nektar Therapeutics
Net Issuance of Common Stock
|
Nektar Therapeutics
Net Issuance of Common Stock Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Nektar Therapeutics
NASDAQ:NKTR
|
Net Issuance of Common Stock
$27m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-14%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Common Stock
$2.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Common Stock
-$4.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
34%
|
CAGR 10-Years
14%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nektar Therapeutics's Net Issuance of Common Stock?
Net Issuance of Common Stock
27m
USD
27m
USD
Based on the financial report for Mar 31, 2024, Nektar Therapeutics's Net Issuance of Common Stock amounts to 27m USD.
What is Nektar Therapeutics's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-14%
-14%
Over the last year, the Net Issuance of Common Stock growth was 4 406%. The average annual Net Issuance of Common Stock growth rates for Nektar Therapeutics have been -3% over the past three years , -49% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
